These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26065451)

  • 1. [Reinstating cloxacilin for empiric antibiotic in late-onset sepsis].
    Sandoval A; Cofré F; Delpiano L; Izquierdo G; Labraña Y; Reyes A
    Rev Chilena Infectol; 2015 Apr; 32(2):182-9. PubMed ID: 26065451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study.
    Lawrence SL; Roth V; Slinger R; Toye B; Gaboury I; Lemyre B
    BMC Pediatr; 2005 Dec; 5():49. PubMed ID: 16375769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices.
    Rubin LG; Sánchez PJ; Siegel J; Levine G; Saiman L; Jarvis WR;
    Pediatrics; 2002 Oct; 110(4):e42. PubMed ID: 12359815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A seven-year survey of management of coagulase-negative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy.
    Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
    Neonatology; 2011; 100(2):180-5. PubMed ID: 21455008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of late-onset sepsis due to coagulase-negative staphylococci in neonatal intensive care units].
    Rasigade JP; Bensaid M; Butin M; Picaud JC; Laurent F
    Arch Pediatr; 2013 Sep; 20(9):1028-33. PubMed ID: 23896085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulase-negative staphylococcal bloodstream infections: Does vancomycin remain appropriate empiric therapy?
    Valencia-Rey P; Weinberg J; Miller NS; Barlam TF
    J Infect; 2015 Jul; 71(1):53-60. PubMed ID: 25725152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy.
    Karlowicz MG; Buescher ES; Surka AE
    Pediatrics; 2000 Dec; 106(6):1387-90. PubMed ID: 11099593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
    Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
    BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric antibiotic regimens for neonatal sepsis in Australian and New Zealand neonatal intensive care units.
    Carr JP; Burgner DP; Hardikar RS; Buttery JP
    J Paediatr Child Health; 2017 Jul; 53(7):680-684. PubMed ID: 28421643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to use vancomycin optimally in neonates: remaining questions.
    Jacqz-Aigrain E; Leroux S; Zhao W; van den Anker JN; Sharland M
    Expert Rev Clin Pharmacol; 2015; 8(5):635-48. PubMed ID: 26289222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus capitis and NRCS-A clone: the story of an unrecognized pathogen in neonatal intensive care units.
    Laurent F; Butin M
    Clin Microbiol Infect; 2019 Sep; 25(9):1081-1085. PubMed ID: 30928561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
    Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM
    Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Options for Persistent Coagulase Negative Staphylococcal Bacteremia in Neonates.
    Gkentzi D; Kolyva S; Spiliopoulou I; Marangos M; Dimitriou G
    Curr Pediatr Rev; 2016; 12(3):199-208. PubMed ID: 27262336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sepsis caused by coagulase-negative Staphylococcus in the newborn infant. Clinical and therapeutic aspects].
    Ginovart Galiana G; Andreu Duat MD; Farré Riba R; Mangues Bafalluy A; Demestre Guasch X; Raspall Torrent F; Altirriba Valls O
    An Esp Pediatr; 1993 Jun; 38(6):488-92. PubMed ID: 8368675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shortening the antibiotic course for the treatment of neonatal coagulase-negative staphylococcal sepsis: fine with three days?
    Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
    Neonatology; 2012; 101(2):101-5. PubMed ID: 21934336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical antimicrobial therapy for late-onset sepsis in a neonatal unit with high prevalence of coagulase-negative Staphylococcus.
    Romanelli RM; Anchieta LM; Bueno E Silva AC; de Jesus LA; Rosado V; Clemente WT
    J Pediatr (Rio J); 2016; 92(5):472-8. PubMed ID: 27112033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset sepsis: comparison between coagulase-negative staphylococci and other bacteria in the neonatal intensive care unit.
    Berlak N; Shany E; Ben-Shimol S; Chertok IA; Goldinger G; Greenberg D; Melamed R
    Infect Dis (Lond); 2018 Oct; 50(10):764-770. PubMed ID: 29969049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of PBP-2A by neonatal mecA-positive coagulase-negative staphylococci (CoNS) blood isolates: β-lactams are useful first-line agents for the treatment of neonatal CoNS sepsis, restricting the use of vancomycin.
    Fleer A; Hemels MA; Paauw A; Krediet TG
    J Antimicrob Chemother; 2012 Jul; 67(7):1616-8. PubMed ID: 22438436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
    Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.